Indian Journal of Psychological Medicine
  Home | About Us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Contact | Advertise | Submission | Login 
Users Online: 1080 
Wide layoutNarrow layoutFull screen layoutHome Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1“Does Ketamine Have Rapid Anti-Suicidal Ideation Effects?”
Laili Soleimani,Alison Welch,James W. Murrough
Current Treatment Options in Psychiatry.2015;2(4)383
[DOI]
2Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice
Jen-Cheng Lin,Mei-Yi Lee,Ming-Huan Chan,Yi-Chyan Chen,Hwei-Hsien Chen
Psychopharmacology.2016;233(17)3223
[DOI]
3Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah,Gerard Sanacora,Ronald S. Duman,John H. Krystal
Annual Review of Medicine.2015;66(1)509
[DOI]
4Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
Francesco Bartoli,Ilaria Riboldi,Cristina Crocamo,Carmen Di Brita,Massimo Clerici,Giuseppe Carrà
Neuroscience & Biobehavioral Reviews.2017;77(1)232
[DOI]
5Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
P A Zunszain,M A Horowitz,A Cattaneo,M M Lupi,C M Pariante
Molecular Psychiatry.2013;18(12)1236
[DOI]
6Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
Elizabeth D. Ballard,Erica M. Richards,Dawn F. Ionescu,Mark J. Niciu,Jennifer Vande Voort,Carlos A. Zarate
Molecular Psychiatry.2014;18(12)209
[DOI]
7Understanding epigenetic architecture of suicide neurobiology: A critical perspective
Bhaskar Roy,Yogesh Dwivedi
Neuroscience & Biobehavioral Reviews.2017;72(12)10
[DOI]
8Ketamina en el tratamiento de la ideación suicida asociada a depresión resistente. A propósito de un caso
Rafael Mora,Salvador López,Mariano Villar,Ramón Palmer,Begoña Rubio
Psiquiatría Biológica.2017;24(1)24
[DOI]
9Comparison of Droperidol and Haloperidol for Use by Paramedics: Assessment of Safety and Effectiveness
Marlow Macht,Ashley C. Mull,Kevin E. McVaney,Emily H. Caruso,J. Bill Johnston,Joshua B. Gaither,Aaron M. Shupp,Kevin D. Marquez,Jason S. Haukoos,Christopher B. Colwell
Prehospital Emergency Care.2014;18(3)375
[DOI]
10KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT?
Samuel T. Wilkinson,Gerard Sanacora
Depression and Anxiety.2016;33(8)711
[DOI]
11Neuroinflammation in suicide: Toward a comprehensive model
Philippe Courtet,Lucas Giner,Maude Seneque,Sebastien Guillaume,Emilie Olie,Deborah Ducasse
The World Journal of Biological Psychiatry.2016;17(8)564
[DOI]
12Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior
Faryal Mallick,Cheryl B. McCullumsmith
Current Psychiatry Reports.2016;18(6)564
[DOI]
13The effects of ketamine on suicidality across various formulations and study settings
David Dadiomov,Kelly Lee
Mental Health Clinician.2019;9(1)48
[DOI]
14Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other Approaches
Rayan K. Al Jurdi,Alan Swann,Sanjay J. Mathew
Current Psychiatry Reports.2015;17(10)48
[DOI]
15Kétamine et dépression : vers de nouvelles perspectives thérapeutiques en soins de support ?
A. Lemaire,M. Plançon,M. Bubrovszky
Psycho-Oncologie.2014;8(1)59
[DOI]
16Definition of treatment-resistant depression – Asia Pacific perspectives
C.H. Ng,T. Kato,C. Han,G. Wang,M. Trivedi,V. Ramesh,D. Shao,S. Gala,S. Narayanan,W. Tan,Y. Feng,S. Kasper
Journal of Affective Disorders.2019;245(1)626
[DOI]
17Ketamine and suicidal ideation in depression: Jumping the gun?
R. Rajkumar,J. Fam,E.Y.M. Yeo,G.S. Dawe
Pharmacological Research.2015;99(1)23
[DOI]
18Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine’s Antidepressant Response and the Development of Ketamine Addiction
Udo Bonnet
Journal of Psychoactive Drugs.2015;47(4)276
[DOI]
19iPlasticity: Induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants
Juzoh Umemori,Frederike Winkel,Giuliano Didio,Maria Llach Pou,Eero Castrén
Psychiatry and Clinical Neurosciences.2018;72(9)633
[DOI]
20Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Y.-D. Hu,Y.-T. Xiang,J.-X. Fang,S. Zu,S. Sha,H. Shi,G. S. Ungvari,C. U. Correll,H. F. K. Chiu,Y. Xue,T.-F. Tian,A.-S. Wu,X. Ma,G. Wang
Psychological Medicine.2016;46(3)623
[DOI]
21Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Philippe Courtet,Bénédicte Nobile,Jorge Lopez-Castroman
Psychological Medicine.2017;46(3)329
[DOI]
22Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Elizabeth D. Ballard,Rebecca B. Price
Psychological Medicine.2016;46(3)43
[DOI]
23Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Déborah Ducasse,Chloé Girod,Philippe Courtet
Psychological Medicine.2016;46(3)111
[DOI]
24Does Ketamine Have Anti-Suicidal Properties? Current Status and Future Directions
Rebecca B. Price,Sanjay J. Mathew
CNS Drugs.2015;29(3)181
[DOI]
25Ketamine as a new treatment for depression: A review of its efficacy and adverse effects
Natalie Katalinic,Rosalyn Lai,Andrew Somogyi,Philip B Mitchell,Paul Glue,Colleen K Loo
Australian & New Zealand Journal of Psychiatry.2013;47(8)710
[DOI]
 Home
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal